Business Description
Nova Mentis Life Science Corp
NAICS : 541714
SIC : 3741
ISIN : CA53069P1018
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.37 | |||||
Equity-to-Asset | -23.88 | |||||
Debt-to-Equity | -0.06 | |||||
Debt-to-EBITDA | -0.18 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -2265.91 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 28.3 | |||||
3-Year EPS without NRI Growth Rate | 27.7 | |||||
3-Year FCF Growth Rate | 25.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.47 | |||||
9-Day RSI | 31.15 | |||||
14-Day RSI | 39.55 | |||||
6-1 Month Momentum % | -17.61 | |||||
12-1 Month Momentum % | -55.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.03 | |||||
Quick Ratio | 0.03 | |||||
Cash Ratio | 0.02 | |||||
Days Sales Outstanding | 99.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -65.3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1203.57 | |||||
Net Margin % | -1171.43 | |||||
FCF Margin % | -161.9 | |||||
ROA % | -304.64 | |||||
ROIC % | -1053.13 | |||||
ROC (Joel Greenblatt) % | -2732.43 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -6.72 | |||||
EV-to-EBITDA | -6.76 | |||||
EV-to-Revenue | 80.82 | |||||
EV-to-FCF | -49.2 | |||||
Earnings Yield (Greenblatt) % | -14.88 | |||||
FCF Yield % | -2.07 |